{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:26:58Z","timestamp":1772753218575,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s551561","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:35:11Z","timestamp":1767954911000},"page":"1-18","source":"Crossref","is-referenced-by-count":1,"title":["Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections"],"prefix":"10.2147","volume":"Volume 20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2610-7980","authenticated-orcid":true,"given":"Yucheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baisen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-9086","authenticated-orcid":true,"given":"Jisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3949\/ccjm.74.suppl_4.s21","volume":"74","author":"Merlino","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"ref2","unstructured":"Centers for Disease Control and Prevention (CDC).Soft tissue infections among injection drug users\u2014San Francisco.California;1996\u20132000. MMWR Morb Mortal Wkly Rep.2001.Vol. 50.381\u2013384."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"ii37","DOI":"10.1093\/jac\/dkh202","volume":"53","author":"DiNubile","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"CD009758","DOI":"10.1002\/14651858.CD009758.pub2","volume":"6","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/QCO.0000000000000239","volume":"29","author":"Esposito","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMcp070747","volume":"357","author":"Daum","year":"2007","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1592\/phco.27.7.1001","volume":"27","author":"TP","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01343.x","volume":"12","author":"Schito","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/antibiotics13090866","volume":"13","author":"Liu","year":"2024","journal-title":"Antibiotics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.amjsurg.2009.08.045","volume":"199","author":"Itani","year":"2010","journal-title":"Am J Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"CD008056","DOI":"10.1002\/14651858.CD008056.pub3","volume":"2016","author":"Yue","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/sur.2012.033","volume":"14","author":"Duane","year":"2013","journal-title":"Surg Infect"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jama.2013.241","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/jac\/dkac073","volume":"77","author":"Zhao","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3870\/j.issn.1004-0781.2023.04.001","volume":"42","author":"Zhao","year":"2023","journal-title":"Drug Eval Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/sur.2020.436","volume":"22","author":"Duane","year":"2021","journal-title":"Surg Infect"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","volume":"13","author":"Sartelli","year":"2018","journal-title":"World J Emerg Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu444","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jiac.2018.01.010","volume":"24","author":"Mikamo","year":"2018","journal-title":"J Infect Chemother"},{"key":"ref21","unstructured":"Zyvox\u00ae (linezolid). Berlin, Germany: Pfizer Pharma GmbH; 2024. package insert."},{"key":"ref22","unstructured":"Sivextro\u00ae (tedizolid phosphate). package insert. Singapore: Bayer PTE LTD; 2024."},{"key":"ref23","unstructured":"Youxitai\u00ae (contezolid). Shanghai, China: Shanghai Mengke Co. Ltd.; 2021. package insert."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.16718\/j.1009-7708.2021.06.027","volume":"21","author":"Yuan","year":"2021","journal-title":"Chin J Infect Chemother"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3969\/j.issn.1008-9926.2024.02.001","volume":"37","author":"Wen","year":"2024","journal-title":"Pharm J Chin People\u2019s Liber Army"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/110850","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/110850","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:35:14Z","timestamp":1767954914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/health-technology-assessment-of-oxazolidinones-for-mrsa-associated-com-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2147\/dddt.s551561","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}